Absci Corporation

News

AMD shadows NVIDIA with a move into AI drug discovery

Chipmaker AMD has taken a 20% stake in Absci, a specialist in the use of artificial intelligence in for biologic drug discovery.

News

AstraZeneca links with Absci on AI for biologics discovery

AstraZeneca has agreed a deal worth up to $247 million with US generative artificial intelligence (GenAI) company Absci that will focus on the discovery of a new antibody-

News

Rare disease, repurposing and the role of AI

Changing Faces: pharma supplier, DTx, and non-profit hires f...

A number of pharma-adjacent tech firms and non-profits announced personnel news in the month of November. We’ve rounded up some highlights below.

AMD shadows NVIDIA with a move into AI drug discovery

AstraZeneca links with Absci on AI for biologics discovery

Changing Faces: pharma supplier, DTx, and non-profit hires f...

NHS "isn't delivering equitable care for rare diseases"

Using AI-driven synthetic personas to take your insights fur...

Editor's Picks